Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - codeine phosphate hemihydrate, quantity: 8 mg; aspirin, quantity: 300 mg - tablet, dispersible - excipient ingredients: citric acid; wheat starch; purified talc; saccharin sodium; calcium carbonate; disodium edetate; sodium lauryl sulfate - for the temporary relief of acute moderate pain, inflammation and fever

United States - English - NLM (National Library of Medicine)

ranbaxy pharmaceuticals inc. - nefazodone hydrochloride (unii: 27x63j94gr) (nefazodone - unii:59h4fcv1tf) - tablet - 50 mg - nefazodone hydrochloride tablets, usp is indicated for the treatment of depression. when deciding among the alternative treatments available for this condition, the prescriber should consider the risk of hepatic failure associated with nefazodone hydrochloride tablets, usp treatment (see warnings ). in many cases, this would lead to the conclusion that other drugs should be tried first. the efficacy of nefazodone in the treatment of depression was established in 6 to 8 week controlled trials of outpatients and in a 6-week controlled trial of depressed inpatients whose diagnoses corresponded most closely to the dsm-iii or dsm-iiir category of major depressive disorder (see clinical pharmacology ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks). it must include either depressed mood or loss of interest or pleasure and at least five of the following nine symptoms: depressed

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - methotrexate - oral tablet - 2.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - methotrexate - oral tablet - 10mg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

cromag pty ltd - bromine present as bromo-chloro-dimethylhydantoin; chlorine present as bromo-chloro-dimethylhydantoin - tablet (inc. pellet, bolus, suppository, capsule) - bromine present as bromo-chloro-dimethylhydantoin mineral-bromine active 650.0 g/kg; chlorine present as bromo-chloro-dimethylhydantoin mineral-chlorine active 280.0 g/kg - algicide - pool | spa | outdoor spa | spa pools - algae | bacteria

Israel - English - Ministry of Health

novartis israel ltd - methotrexate - tablets - methotrexate 2.5 mg - methotrexate - methotrexate - the treatment of acute lymphoblastic leukaemia and burkitt's lymphoma. the treatment of severe cases of uncontrolled psoriasis, unresponsive to conventional therapy. the treatment of adults with severe, active, classical or definite rheumatoid arthritis who are unresponsive or intolerant to conventional therapy.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

klorman industries pty ltd - bromine; chlorine present as bromo-chloro-dimethylhydantoin - tablet (inc. pellet, bolus, suppository, capsule) - bromine mineral-bromine active 650.0 g/kg; chlorine present as bromo-chloro-dimethylhydantoin mineral-chlorine active 280.0 g/kg - pool algicide - heated pool | hot tub | spa | outdoor spa | spa | spa pools - algae | bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fluidra group australia pty ltd - bromine; chlorine present as bromo-chloro-dimethylhydantoin - tablet (inc. pellet, bolus, suppository, capsule) - bromine mineral-bromine active 650.0 g/kg; chlorine present as bromo-chloro-dimethylhydantoin mineral-chlorine active 280.0 g/kg - pool algicide

United States - English - NLM (National Library of Medicine)

watson labs - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - tablet - 250 mg - carefully consider the potential benefits and risks of naproxen and other treatment options before deciding to use naproxen. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). naproxen tablets are indicated: - for relief of mild to moderate pain for relief of mild to moderate pain - for relief of signs and symptoms of juvenile arthritis for relief of signs and symptoms of juvenile arthritis - for relief of the signs and symptoms of rheumatoid arthritis for relief of the signs and symptoms of rheumatoid arthritis - for relief of the signs and symptoms of osteoarthritis for relief of the signs and symptoms of osteoarthritis - for treatment of primary dysmenorrhea for treatment of primary dysmenorrhea - for acute or long-term use in the relief of signs and symptoms of the following: ankylosing spondylitis acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis) acute gouty arthritis for acute or long-

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875 gpo 00100 nairobi kenya - phenytoin sodium - tablet - 100 mg per tablet - antiepileptics: hydantoinderivatives